EUVIMEDEUVIMED entdecken
Crossref

Cardiovascular toxicities associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event reporting system

Feifei Wang iD, Xinan Wu

Journal of Clinical Pharmacy and Therapeutics · 2022-10 · 47 (10) · 1576-1584

DOI: 10.1111/jcpt.13707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 20.06.2022. Verfasst von Feifei Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Hefei BOE Hospital, Hefei, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Immunological, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, ImmunologicalNeoplasmsAgedFemaleHumansImmune Checkpoint InhibitorsLungMaleMiddle AgedPharmacovigilanceUnited StatesUnited States Food and Drug Administration

Stichwörter der Autor:innen

adverse event reporting systemcardiovascular adverse eventimmune checkpoint inhibitors

Substanzen

Antineoplastic Agents, ImmunologicalImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, Hefei BOE Hospital, Hefei, People's Republic of China.

ORCID-Profile: Feifei Wang

Zitieren

APA

Wang, F., & Wu, X. (2022). Cardiovascular toxicities associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event reporting system. Journal of Clinical Pharmacy and Therapeutics, 47(10), 1576-1584. https://doi.org/10.1111/jcpt.13707

Vancouver

Wang F, Wu X. Cardiovascular toxicities associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event reporting system. Journal of Clinical Pharmacy and Therapeutics. 2022;47(10):1576-1584. doi:10.1111/jcpt.13707

BibTeX
@article{Wang2022,
  author = {Wang, Feifei and Wu, Xinan},
  title = {Cardiovascular toxicities associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event reporting system},
  journal = {Journal of Clinical Pharmacy and Therapeutics},
  year = {2022},
  volume = {47},
  number = {10},
  pages = {1576--1584},
  doi = {10.1111/jcpt.13707}
}
Kostenlos starten →